<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00929682</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0055</org_study_id>
    <nct_id>NCT00929682</nct_id>
  </id_info>
  <brief_title>Levobupivacaine for Epidural Analgesia in Labour</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      In a prospective randomised study involving primiparous women in spontaneous uncomplicated
      labour with cervical dilatation &gt; 7 cm, epidural analgesia will be given with an initial
      volume of 20 mL anaesthetic solution, followed by a standardised algorithm of top-up manual
      injections to achieve analgesia, then by a patient-controlled regimen with 5-mL
      self-administered boli in addition to a continuous infusion of 5 mL.hr-1. The anaesthetic
      solution will be levobupivacaine presented in 100-mL bags from the market, 0.0625%, or
      0.125%, in which 10 mL (50 µg) of sufentanil will be added. The final concentrations will be
      0.568 and 1.136 mg.mL-1 respectively, both with sufentanil 0.45 µg.mL-1. Parturients and
      midwifes assessing pain during labour will be blinded to the design
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since epidural analgesia has been developed to relieve labour pain, many solutions have
      emerged to lower risk / efficacy ratio, by using low-concentrated and/or less toxic local
      anaesthetics. Levobupicaine emerges as a safer alternative than its racemic parent . It is
      available on the French market in pre-filled bags with two different concentrations (0.625
      and 1.25 mg.mL-1), both indicated for analgesia in postoperative context and in labour,
      without more precision. Presentation in bags allows preparing once at the initiation of
      epidural analgesia a solution usable throughout labour, leading the anaesthetist to a
      univocal choice, mostly following his/her personal beliefs. Our aim is to compare the effects
      of epidural analgesia under these two presentations. Sufentanil will be added to
      levobupicaine whatever the concentration used. This trial is conducted in primiparous, in
      which pain during labour is commonly more resistant to relief.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>- Spontaneous pain during labour (on VAS). - Number of required additional epidural boluses, either self-administered or medically given as a rescue.</measure>
    <time_frame>during labour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Pain at delivery - Pain at post-delivery sutures - Motor block - Duration of labour - Obstetrical events (cesarean, instrumental delivery)</measure>
    <time_frame>during labour</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">136</enrollment>
  <condition>Analgesia, Epidural</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine 0.568mg.mL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine 1.136mg.mL</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Randomization between two referenced treatments</intervention_name>
    <description>Levobupivacaine 0.568 mg.mL-1 and sufentanil 0.45 g.mL-1, 20 mL epidurally for induction, then by a patient-controlled regimen with 5-mL self-administered boli in addition to a continuous infusion of 5 mL.hr-1.
Same protocol, with levobupivacaine 1.136 mg.mL-1 and sufentanil 0.45 g.mL-1.</description>
    <arm_group_label>Levobupivacaine 0.568mg.mL</arm_group_label>
    <arm_group_label>Levobupivacaine 1.136mg.mL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parturient &gt; 18 years old

          -  ASA physical status 1 or 2

          -  Primiparity

          -  Singleton

          -  Gestational age &gt; 36 weeks

          -  Spontaneous labour with cervical dilatation &gt; 7 cm

        Exclusion Criteria:

          -  Gestational age &lt; 36 weeks
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martine Bonnin, MB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/20565392</url>
  </link>
  <results_reference>
    <citation>Tixier S, Bonnin M, Bolandard F, Vernis L, Lavergne B, Bazin JE, Dualé C. Continuous patient-controlled epidural infusion of levobupivacaine plus sufentanil in labouring primiparous women: effects of concentration. Anaesthesia. 2010 Jun;65(6):573-80. doi: 10.1111/j.1365-2044.2010.06369.x.</citation>
    <PMID>20565392</PMID>
  </results_reference>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2009</study_first_submitted>
  <study_first_submitted_qc>June 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2009</study_first_posted>
  <last_update_submitted>April 2, 2013</last_update_submitted>
  <last_update_submitted_qc>April 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Labor</keyword>
  <keyword>Epidural analgesia</keyword>
  <keyword>Local anesthetics</keyword>
  <keyword>Levobupivacaine</keyword>
  <keyword>Opiates</keyword>
  <keyword>Patient-controlled</keyword>
  <keyword>Active spontaneous labor requiring epidural analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

